Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 886.46K | 468.51K | 110.14K | 23.94K | 21.28K |
Gross Profit | 886.46K | 254.29K | -61.14K | -77.02K | -50.22K |
EBITDA | -4.61M | 10.70M | -2.94M | -1.94M | -795.89K |
Net Income | -439.53K | 10.37M | 4.98M | -2.15M | -1.04M |
Balance Sheet | |||||
Total Assets | 95.45M | 66.53M | 55.33M | 33.14M | 25.62M |
Cash, Cash Equivalents and Short-Term Investments | 5.19M | 10.77M | 13.64M | 6.50M | 5.79M |
Total Debt | 1.20M | 1.75M | 1.54M | 1.61M | 1.64M |
Total Liabilities | 2.51M | 2.96M | 2.59M | 2.37M | 2.40M |
Stockholders Equity | 92.94M | 63.57M | 52.75M | 30.76M | 23.22M |
Cash Flow | |||||
Free Cash Flow | -7.71M | -2.80M | -9.57M | -8.70M | -4.24M |
Operating Cash Flow | -6.00M | -2.32M | -2.51M | -2.15M | -1.14M |
Investing Cash Flow | 1.06M | -462.49K | -6.95M | -6.57M | -2.33M |
Financing Cash Flow | -643.79K | -86.47K | 16.60M | 9.43M | 6.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
55 Neutral | AU$103.01M | ― | -21.82% | ― | ― | -525.27% | |
46 Neutral | AU$100.64M | ― | -15.33% | ― | -52.53% | -27.29% | |
45 Neutral | AU$87.64M | 6.07 | -0.45% | ― | ― | -103.57% | |
45 Neutral | AU$119.09M | ― | -141.59% | ― | 562.03% | -336.00% | |
44 Neutral | AU$1.40B | -6.65 | -23.02% | 6.57% | 5.33% | -26.92% | |
37 Underperform | AU$82.08M | ― | -13.69% | ― | -100.00% | -88.89% |
Diatreme Resources Limited has announced a significant upgrade to its Mineral Resource Estimate for the Si2 Deposit in the Northern Silica Project, with a 278% increase in Measured Mineral Resource to 187.5Mt. This upgrade enhances the company’s geological confidence and supports its plans for a 25-year mining operation, positioning Diatreme as a key player in the photovoltaic silica market.
Diatreme Resources Limited’s Northern Silica Project (NSP) has been awarded Major Project Status by the Australian Government, marking it as the first project in Queensland to receive this designation. This status provides Diatreme with enhanced support for federal approvals and aligns with Australia’s Critical Minerals Strategy, highlighting the project’s potential for regional economic growth and its strategic importance in the clean energy sector. The NSP is expected to significantly contribute to the local economy, providing over 120 direct jobs and supporting regional infrastructure development, while also advancing through its final permitting and development phases.
Diatreme Resources Limited has announced the extension of its $1.0 million debt facility for an additional 12 months, now maturing on 30 May 2026. This extension, which maintains a 7.5% interest rate, is crucial for protecting shareholder value and supporting the development of Diatreme’s silica sand projects in Queensland. The extension reflects ongoing support from lender Ms. Jie Wu and reinforces Diatreme’s strategic positioning in the silica sand industry, with potential implications for stakeholders in terms of project development and financial stability.
Diatreme Resources Limited has strengthened its position as Australia’s leading silica sands miner through the successful acquisition of Metallica Minerals Limited, expanding its resource base to 463 million tonnes. The company is advancing its Northern Silica Project with regulatory approvals and has secured international partnerships, positioning itself to meet the growing demand from the global solar industry.
Diatreme Resources announced the sale of a dormant intellectual property asset related to scandium extraction, generating $562,500 to support its silica sand project development. Despite reporting a net loss of $439,527 for the fiscal year, the company highlighted a significant expansion of its silica sand resources. As of March 31, 2025, Diatreme’s cash and liquid assets totaled $4.2 million, with an additional $13.7 million in joint ventures, totaling $17.9 million.
Diatreme Resources Limited has released its corporate governance statement for the financial year ending December 31, 2024, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles, highlighting their commitment to transparency and accountability. This move is expected to bolster stakeholder confidence and reinforce Diatreme’s reputation in the industry by demonstrating their compliance with governance standards.
Diatreme Resources Limited has released its Annual Report for 2024, highlighting key achievements and financial performance. The report includes comprehensive details on the company’s environmental, social, and governance initiatives, as well as its financial statements, which indicate a strategic focus on sustainable growth and stakeholder engagement.
Diatreme Resources Limited has announced its Annual General Meeting (AGM) scheduled for May 22, 2025, in Brisbane. The meeting will cover the company’s financial statements, directors’ and auditors’ reports for the year ending December 31, 2024. Shareholders are encouraged to participate by submitting proxy forms by May 20, 2025. The agenda includes a non-binding resolution on the remuneration report, which will be advisory and not binding on the company or its directors.